Robert W. Hesslein, Senior VP & General Counsel at Voyager Therapeutics, Inc. (VYGR), sold 4,955 shares at $8.68 ($41K) on 2022-03-21, disclosed to the SEC on 2022-03-23.
Scheduled sale ($41k) by Senior VP & General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.29 | 4,897 | $41K | 98.8% |
| 2 | $8.68 | 58 | $503 | 1.2% |
| Total | $8.29 avg | 4,955 | $41K | 100% |
| Filing → |
| VYGR | SELL | 2023-02-15 | $22K | — | Filing → |
| VYGR | SELL | 2023-01-19 | $22K | — | Filing → |
| VYGR | SELL | 2022-04-06 | $23K | — | Filing → |